Skip to content
stoqly

DIEBOLD NIXDORF, Inc

DBD NYSE Calculating & Accounting Machines (No Electronic Computers) Financials FY2015–FY2025

Revenue Total sales reported in the income statement.
$3.8B
vs prior year
Operating margin Operating income as a share of revenue.
6.4%
Net income Profit after all expenses, interest and tax.
$94.6M
Free cash flow Cash from operations minus capital spending.
β€”
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
11.9%
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $3.01 EPS (TTM)

What DIEBOLD NIXDORF, Inc does

No business description yet.

Legal name
DIEBOLD NIXDORF, Inc
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 12, 2026
Accession Β· CIK
0000028823-26-000008
0000028823

Revenue and margins

DIEBOLD NIXDORF, Inc had $3.8B of revenue in fiscal 2025.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2015 to 2025, diluted EPS grew 9.5% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was β€” in fiscal 2025, β€” of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

DIEBOLD NIXDORF, Inc returned $131M to shareholders in fiscal 2025. The diluted share count rose 0.0%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably DIEBOLD NIXDORF, Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY20FY21FY22FY24FY25
Cash and short-term investments $362M$423M$332M$313M$398M
Debt incl. finance leases $2.3B$2.2B$2.6B$948M$965M
Net debt / EBITDA 20.3x8.8xβ€”β€”1.5x
Debt / equity β€”β€”β€”1.0x0.9x
Interest coverage 0.1x0.7xβˆ’1.1xβ€”2.8x
Current ratio 1.1x1.1x1.1x1.3x1.3x
Quick ratio 0.8x0.8x0.7x0.9x0.9x
Total assets $3.7B$3.5B$3.1B$3.5B$3.9B
Total liabilities $4.5B$4.4B$4.4B$2.6B$2.7B
Shareholders' equity βˆ’$827Mβˆ’$845Mβˆ’$1.4B$930M$1.1B
Net debt (βˆ’ = net cash) $2.0B$1.8B$2.2B$635M$567M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY15FY16FY17FY18FY19FY20FY21FY22FY25
Net income is positive βœ“ βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ“
Cash from operations is positive βœ“ βœ“ βœ“ βœ• βœ“ βœ“ βœ“ βœ• βœ“
Return on assets rose β€” βœ• βœ• βœ• βœ“ βœ“ βœ“ βœ• β€”
Cash from operations exceeds net income βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ“
Current ratio rose β€” βœ• βœ• βœ“ βœ• βœ• βœ• βœ“ βœ•
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ• β€”
Gross margin rose β€” βœ• βœ“ βœ• βœ“ βœ“ βœ“ βœ• β€”
Revenue rose relative to assets β€” βœ• βœ“ βœ“ βœ“ βœ• βœ“ βœ“ β€”
F-score β€” / 32 / 94 / 93 / 95 / 94 / 95 / 93 / 9β€” / 5
Accruals ratio 1.6%βˆ’1.9%βˆ’5.3%βˆ’9.0%βˆ’11.8%βˆ’7.7%βˆ’5.6%βˆ’5.9%βˆ’5.6%
Altman Z'' 3.531.321.070.32βˆ’0.08βˆ’0.44βˆ’0.45βˆ’1.931.63

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY15FY16FY17FY18FY19FY20FY21FY22FY24FY25
Income statement
Revenue $2.4B $3.3B $4.6B $4.6B $4.4B $3.9B $3.9B $3.5B β€” $3.8B
Provision for credit losses $0.2M β€” $0.1M β€” β€” β€” β€” β€” β€” β€”
Gross profit $652M $712M $1,000M $899M $1.1B $1.0B $1.0B $757M β€” $961M
Research and development $86.9M $110M $156M $157M $147M $133M $126M $121M β€” $86.7M
Operating income $58.6M βˆ’$170M βˆ’$93.5M βˆ’$326M βˆ’$26.6M $24.0M $137M βˆ’$212M β€” $242M
Interest expense $32.5M $101M $117M $155M $203M $267M $195M $199M β€” $85.7M
Pretax income $45.8M βˆ’$249M βˆ’$192M βˆ’$478M βˆ’$229M βˆ’$270M βˆ’$50.7M βˆ’$439M β€” $125M
Income tax βˆ’$13.7M βˆ’$69.0M $28.3M $37.2M $117M βˆ’$1.0M $27.7M $149M β€” $24.1M
Net income $73.7M βˆ’$41.6M βˆ’$242M βˆ’$531M βˆ’$341M βˆ’$269M βˆ’$78.8M βˆ’$581M β€” $94.6M
Diluted EPS $1.12 βˆ’$0.60 βˆ’$3.20 βˆ’$7.48 βˆ’$4.45 βˆ’$3.47 βˆ’$1.01 βˆ’$7.36 β€” $2.54
Diluted shares 0.07B 0.07B 0.08B 0.08B 0.08B 0.08B 0.08B 0.08B β€” 0.04B
Cash flow
Cash from operations $37.2M $28.7M $37.1M βˆ’$104M $136M $18.0M $123M βˆ’$388M β€” $301M
Depreciation and amortization $64.0M $135M $252M $248M $226M $73.7M $70.9M $56.4M β€” $128M
Stock-based compensation $12.4M $22.2M $33.9M $36.6M $24.0M $14.9M $13.8M $13.4M β€” $12.1M
Acquisitions $59.4M $885M $5.6M $5.9M $0.0M $0.0M β€” β€” β€” $24.5M
Share buybacks $3.0M $2.2M $5.0M $3.0M $1.9M $6.6M $7.7M $7.8M β€” $131M
Dividends paid $75.6M $64.6M $30.6M $7.7M $0.0M $0.0M β€” β€” β€” β€”
Dividends and buybacks $78.6M $66.8M $35.6M $10.7M $1.9M $6.6M $7.7M $7.8M β€” $131M
Balance sheet
Cash and short-term investments $314M $653M $535M $458M $281M $362M $423M $332M $313M $398M
Total debt $606M $1.7B $1.8B $2.2B $2.1B $2.3B $2.2B $2.6B $927M $939M
Finance lease liabilities β€” β€” β€” β€” $2.3M $4.9M β€” β€” $20.3M $26.8M
Current assets $1.6B $2.6B $2.5B $2.2B $1.9B $1.9B $1.9B $1.8B $1.7B $1.8B
Current liabilities $956M $1.8B $1.8B $1.6B $1.6B $1.6B $1.7B $1.6B $1.3B $1.4B
Inventory $369M $738M $715M $610M $467M $498M $544M $588M $528M $521M
Property and equipment, net $175M $387M $365M $304M $232M $178M $138M $121M $128M β€”
Goodwill $162M $998M $1.0B $798M $764M $800M $744M $702M $586M $642M
Intangible assets $67.5M $773M $774M $625M $502M $449M $348M $258M $779M $792M
Total assets $2.2B $5.3B $5.2B $4.3B $3.8B $3.7B $3.5B $3.1B $3.5B $3.9B
Total liabilities $1.8B $4.7B $4.8B $4.4B $4.3B $4.5B $4.4B $4.4B $2.6B $2.7B
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M β€” β€”
Shareholders' equity $412M $589M $446M βˆ’$150M βˆ’$530M βˆ’$827M βˆ’$845M βˆ’$1.4B $930M $1.1B
Margins
Gross margin 26.9% 21.5% 21.7% 19.6% 24.2% 26.5% 26.7% 21.9% β€” 25.3%
Operating margin 2.4% βˆ’5.1% βˆ’2.0% βˆ’7.1% βˆ’0.6% 0.6% 3.5% βˆ’6.1% β€” 6.4%
EBITDA margin 5.1% βˆ’1.1% 3.4% βˆ’1.7% 4.5% 2.5% 5.3% βˆ’4.5% β€” 9.7%
Net margin 3.0% βˆ’1.3% βˆ’5.2% βˆ’11.6% βˆ’7.7% βˆ’6.9% βˆ’2.0% βˆ’16.8% β€” 2.5%
Returns
Return on capital 8.3% βˆ’8.2% βˆ’4.4% βˆ’16.3% βˆ’1.6% 1.7% 11.1% βˆ’19.8% β€” 11.9%
Return on capital employed 4.6% βˆ’4.9% βˆ’2.7% βˆ’12.0% βˆ’1.2% 1.2% 7.8% βˆ’14.5% β€” 9.7%
Return on equity 17.9% βˆ’8.3% βˆ’46.7% βˆ’359.3% β€” β€” β€” β€” β€” 9.3%
Return on assets 3.3% βˆ’1.1% βˆ’4.6% βˆ’11.2% βˆ’8.5% βˆ’7.2% βˆ’2.2% βˆ’17.7% β€” 2.6%
Return on tangible equity 40.2% β€” β€” β€” β€” β€” β€” β€” β€” β€”
Growth
Revenue growth β€” 37.1% 39.0% βˆ’0.7% βˆ’3.7% βˆ’11.5% 0.1% βˆ’11.4% β€” β€”
Net income growth β€” βˆ’156.4% β€” β€” β€” β€” β€” β€” β€” β€”
EPS growth β€” βˆ’153.6% β€” β€” β€” β€” β€” β€” β€” β€”
Share count change β€” 5.3% 9.3% 0.7% 0.9% 1.2% 0.9% 0.9% β€” β€”
Financial health
Net debt / EBITDA 2.4x β€” 7.9x β€” 9.2x 20.3x 8.8x β€” β€” 1.5x
Debt / equity 1.5x 2.9x 4.0x β€” β€” β€” β€” β€” 1.0x 0.9x
Interest coverage 1.8x βˆ’1.7x βˆ’0.8x βˆ’2.1x βˆ’0.1x 0.1x 0.7x βˆ’1.1x β€” 2.8x
Current ratio 1.7x 1.4x 1.4x 1.4x 1.2x 1.1x 1.1x 1.1x 1.3x 1.3x
Quick ratio 1.3x 1.0x 1.0x 1.0x 0.9x 0.8x 0.8x 0.7x 0.9x 0.9x
Capital allocation
Stock comp / revenue 0.5% 0.7% 0.7% 0.8% 0.5% 0.4% 0.4% 0.4% β€” 0.3%
Quality scores
Piotroski F-score β€” 2.0 4.0 3.0 5.0 4.0 5.0 3.0 β€” β€”
Altman Z'' 3.5 1.3 1.1 0.3 βˆ’0.1 βˆ’0.4 βˆ’0.4 βˆ’1.9 β€” 1.6
Accruals ratio 1.6% βˆ’1.9% βˆ’5.3% βˆ’9.0% βˆ’11.8% βˆ’7.7% βˆ’5.6% βˆ’5.9% β€” βˆ’5.6%

Source: SEC EDGAR XBRL filings (CIK 0000028823). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open